analiza aiqbench
Major AI companies are uniting to urge US lawmakers to mandate screening for synthetic DNA and RNA purchases, aiming to close a biosecurity gap where AI could lower barriers to designing dangerous pathogens. This coordinated effort highlights a critical regulatory shift where industry rivals prioritize collective safety over commercial competition to prevent potential pandemics driven by accessible genetic tools. The move signals that AI's increasing capability in protein prediction and sequence design is prompting immediate policy interventions to mitigate misuse risks.
AI leaders call for tougher protections against AI-aided bioweapons
Some of the AI industry's biggest rivals have put their many, many grievances aside for a common cause: making it harder for people to use their technology to develop biological weapons. In an open letter to US lawmakers, tech leaders are pressing Congress to enact rules closing what they say is an alarming biosecurity gap that could help trigger a global pandemic. Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman are among the signatories urging US lawmakers to require companies selling synthetic DNA and RNA - genetic material that can ordered online and assembled in a lab - to screen purchases for sequences t … Read the full story at The Verge.
Some of the AI industry’s biggest rivals have put their many, many grievances aside for a common cause: making it harder for people to use their technology to develop biological weapons. In an open letter to US lawmakers, tech leaders are pressing Congress…
Extras afișat conform termenilor RSS ai publicației · 43 cuvinte · textul integral și figurile sunt pe site-ul publicației
Subiecte conexe
Digital States 2026: AI Moves From Experiment to Infrastructure
govtech.com · 24 sept. 2026
BRICS Draws a New Global Line: Full Text of New Delhi Declaration
slguardian.org · 12 sept. 2026
Problems of Proliferation
LessWrong · 29 sept. 2026
I Did This Without Your Knowledge
LessWrong · 17 oct. 2026